- Technical notes
- Cellartis MSC Xeno-Free Culture Medium
- Cellartis Power Primary HEP Medium
- Cellartis DEF-CS 500 Culture System
- Cellartis Enhanced hiPS-HEP cells
- Cellartis hES-MP 002.5
- Cellartis hPS cell-derived cardiomyocytes
- Cellartis iPS Cell to Hepatocyte Differentiation System
- 2i mES/iPSC medium
- 3i mES/iPSC medium
- NDiff 227
- NDiff N2
- Selection guides
Cellartis hES-MP 002.5 citation list
hES-MP 002.5 cells are human embryonic stem (ES) cell-derived multipotent mesenchymal progenitors that can be differentiated into several mesodermal lineages. The cells are derived from the SA002.5 ES cell line, a subclone of SA002, known for efficient osteogenic lineage differentiation and high mineralization potential with extended culture. Read below for a citation list of studies in which hES-MP 002.5 cells were used in peer-reviewed basic, translational, preclinical, and biomedical research.
Bigdeli, N. et al. Superior osteogenic capacity of human embryonic stem cells adapted to matrix-free growth compared to human mesenchymal stem cells. Tissue Eng. Part A 16, 3427–40 (2010).
Both, S. K. et al. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells. J. Tissue Eng. Regen. Med. 5, 180–90 (2011).
de Peppo, G. M. et al. Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications. Tissue Eng. Part A 16, 2161–82 (2010).
de Peppo, G. M. et al. Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng. Part A 16, 3413–26 (2010).
de Peppo, G. M. et al. Free-form-fabricated commercially pure Ti and Ti6Al4V porous scaffolds support the growth of human embryonic stem cell-derived mesodermal progenitors. ScientificWorldJournal. 2012, 646417 (2012).
Karlsson, C. et al. Human embryonic stem cell-derived mesenchymal progenitors—potential in regenerative medicine. Stem Cell Res. 3, 39–50 (2009).
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2022 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.